Silco Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 5, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	1,661	1,536	1,754	2,533	2,741	2,709
Market Cap Growth	-0.62%	-12.43%	-30.74%	-7.58%	1.15%	16.52%
Enterprise Value	1,628	1,518	1,703	2,491	2,643	2,599
Last Close Price	16.00	14.68	16.66	23.75	25.15	23.90
PE Ratio	39.00	36.02	38.24	36.59	32.45	32.01
PS Ratio	3.85	3.56	4.28	5.45	4.90	4.51
PB Ratio	0.69	0.64	0.75	1.09	1.20	1.20
P/TBV Ratio	0.69	0.64	0.75	1.09	1.20	1.20
P/FCF Ratio	225.68	203.70	32375.63	-	43.53	-
P/OCF Ratio	25.39	19.88	20.81	14.03	16.21	10.53
EV/Sales Ratio	3.78	3.52	4.15	5.36	4.72	4.32
EV/EBITDA Ratio	9.48	9.07	11.52	16.19	15.35	16.88
EV/EBIT Ratio	20.94	19.39	28.78	37.09	27.12	32.74
EV/FCF Ratio	221.14	201.24	31423.90	-	41.99	-
Debt / Equity Ratio	0.00	0.00	0.00	-	0.00	0.00
Debt / EBITDA Ratio	0.01	0.03	0.06	-	0.02	0.05
Debt / FCF Ratio	0.34	0.66	176.56	-	0.07	-
Net Debt / Equity Ratio	-0.01	-0.01	-0.01	-0.02	-0.03	-0.03
Net Debt / EBITDA Ratio	-0.20	-0.13	-0.14	-0.32	-0.35	-0.42
Net Debt / FCF Ratio	-4.54	-2.82	-385.79	33.89	-0.96	0.54
Asset Turnover	-	0.16	0.15	0.17	0.21	0.23
Inventory Turnover	-	0.62	0.63	0.71	0.82	0.96
Quick Ratio	2.13	2.03	1.45	1.45	1.56	1.64
Current Ratio	4.76	4.71	3.39	3.40	3.61	3.72
Return on Equity (ROE)	-	1.80%	1.96%	3.01%	3.72%	3.75%
Return on Assets (ROA)	-	1.75%	1.32%	1.53%	2.25%	1.85%
Return on Invested Capital (ROIC)	1.78%	1.82%	1.98%	2.32%	3.42%	3.57%
Return on Capital Employed (ROCE)	3.00%	3.10%	2.40%	2.70%	4.00%	3.30%
Earnings Yield	2.55%	2.78%	2.61%	2.73%	3.08%	3.12%
FCF Yield	0.44%	0.49%	0.00%	-0.06%	2.30%	-4.40%
Dividend Yield	0.74%	0.75%	0.60%	1.26%	1.99%	4.18%
Payout Ratio	14.46%	15.82%	41.72%	45.43%	74.15%	73.25%
Total Shareholder Return	1.05%	0.75%	0.60%	1.26%	1.99%	4.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.